Introduction {#s1}
============

A recent review of dietary intake data from Asia showed that recommended daily intakes of many essential micronutrients, such as vitamin A, iron, calcium, riboflavin, zinc and iodine, were not met [@pone.0034906-Solomons1]. This is also the situation for Vietnam where besides micronutrient intake, macronutrient intake is also too low [@pone.0034906-Hoang1]. Indeed, the food consumption survey conducted in 2009 showed that 20% of the Vietnamese population was not meeting its energy requirements (personal communication), against 40% in 2005 [@pone.0034906-Hoang1]. In 2005, the energy intake comes from a predominantly rice based diet, with an average rice consumption of over 350 g/d [@pone.0034906-Hoang1]. This diet also results in low intakes of micronutrients with over 70% of Vietnamese population consuming less than the recommended amounts of most micronutrients [@pone.0034906-Hoang1]. Over the last decade, Vietnam experienced a period of rapid economic growth [@pone.0034906-Vietnam1] and a reduction in poverty from 37.4% in 1998 to 16% in 2006 [@pone.0034906-GSO1], and to 13.4% in 2008 [@pone.0034906-GSO2]. In the same time, nutrient intakes, especially vitamins, increased significantly [@pone.0034906-Hoang1].

In parallel to dietary intake data, nutritional status as measured by anthropometry has improved over the last decades but remains of concern. The prevalence of underweight among children under 5 years of age declined from 45% in 1990 to 26.6% in 2004 [@pone.0034906-Khan1] and the prevalence of stunting decreased from 60% in 1985 to 30% in 2005 [@pone.0034906-Khan2]. Moreover, recent intervention pilot studies showed that the prevalence of anemia ranges from 25% to 45% in schoolchildren [@pone.0034906-Nga1], [@pone.0034906-Liendo1] and 24% in women of reproductive age [@pone.0034906-VanThuy1]. In addition, the prevalence of zinc and selenium deficiencies were also reported to be very high (\>50%) in rural Vietnamese children [@pone.0034906-Vu1]. However, another study carried out in 2008 in two Vietnamese provinces of the Mekong of Delta among women of reproductive age did not show evidence of folate and vitamin B~12~ deficiencies, although many women had marginal folate status [@pone.0034906-Vu1].

Over the last 10 years, a number of trials conducted in Vietnam have demonstrated the efficacy of micronutrient fortification of fish sauce [@pone.0034906-VanThuy1], [@pone.0034906-Thuy1], milk [@pone.0034906-Liendo1], biscuits [@pone.0034906-Nga1], [@pone.0034906-Khoury1], complementary food [@pone.0034906-Phu1], instant noodles [@pone.0034906-Le1], [@pone.0034906-LeHuong1] and of micronutrient supplements [@pone.0034906-Huy1], [@pone.0034906-Casey1], [@pone.0034906-Berger1], to reduce micronutrient deficiencies among several population groups (infants, preschool and school-aged children, and women of reproductive age).

Controlling micronutrient deficiencies has been one of the priorities for the Vietnamese government in the 2001--2010 National Nutrition Strategy and is still a priority in the 2011--2020 National Nutrition Strategy. However, to develop a comprehensive national plan of interventions, there is an urgent need for national data on vitamin and mineral deficiencies. In 2009 a nationwide food consumption survey (FCS) was carried out among young children and women of reproductive age. The present study was carried-out on a subset of households from the FCS that were re-surveyed in 2010 to provide additional information on iron, zinc, vitamin A, vitamin B12 and folate status of women in reproductive age and young children, in relation to their living area (urban/rural) and socio-economical status.

Materials and Methods {#s2}
=====================

Study design and sampling {#s2a}
-------------------------

The survey population of the 2009 FCS consisted of 7680 households (HH), sampled from 512 clusters (104 urban and 408 rural). HH were randomly selected using a stratified 2-stage cluster sampling procedure with probability proportionate to size (PPS). A subset of HH from the FCS was selected for this 2010 micronutrient study (MNS). The sample size for this study was estimated on the basis of a prevalence of anemia among women of reproductive age of 50% as in the latest anemia national survey implemented in 1995, 39.9% of the non-pregnant and 52.5% of pregnant women were anemic [@pone.0034906-LeHung1]. Therefore, a sample size of 694 women per stratum (urban/rural) was calculated to get a precision of 5.0% with an expected design effect of 2.0. Anticipating an estimated 17% refusal or absence of women in the selected HH, 840 HH per stratum were required. Consequently a total of 56 urban and 56 rural clusters of 15 households were selected for this study. Every woman and every child from 6 months to 7 years of the selected households were surveyed. With an estimation of 0.28 child per household in the age range of 6--59 months, the study planned to recruit at least 470 children. Due to limited funding, 19 provinces were first selected by NIN at random on the list of the 64 provinces to pick 56 urban clusters from those selected for the 2009 FCS. Thereafter, 56 rural clusters also from those selected for the 2009 FCS were randomly selected in the same 19 provinces. Selected households were incorporate in the study with assistance of local guides who were involved in the 2009 FCS.

Inclusion and exclusion criteria {#s2b}
--------------------------------

The women of reproductive age were selected according to the following criteria: i) Living in households having participated in the 2009 food consumption survey; ii) Non-pregnant women aged 15--49 years; iii) No reported severe or chronic illness; iv) No reported or diagnosed current fever, diarrhea, ARI, or other acute infections; v) Having signed the informed consent form to participate.

The criteria for children less than six years to participate in the survey were as follows: i) From households having participated in the 2009 food consumption survey; ii) No reported severe or chronic illness, including congenital abnormalities, mental or severe physical handicap; iii) No reported or diagnosed current fever, diarrhea, ARI, or other acute infections; iv) Written informed consent signed by at least one parent.

Anthropometry {#s2c}
-------------

Selected women and children were invited to come to the Commune Health Center early morning. Children and women were weighed without shoes or sandals and wearing light clothes by using a balance with a precision of 0.1 kg (Body Composition Monitor Scale Tanita BC-543, Japan). Height was measured by using a height measuring device with a precision of 0.1 cm (wooden height board, UNICEF). For children under two years, measurement of recumbent length was taken on an adjustable child length measuring board with a precision of 0.1 cm (wooden length board, UNICEF).

Anthropometric data were entered through EpiData (version 6.0, CDC). For children from 6 months to 6 years, anthropometric z-scores were calculated using the National Center for Health Statistics/WHO growth reference data of 2006 [@pone.0034906-deOnis1], using the Access Visual Basic program incorporating tables from the WHO Anthro software for standard population. Anthropometric status was assessed by the following indicators: weight-for-age\<-2z-scores (WAZ) for underweight, height-for-age\<-2 z-scores (HAZ) for stunting and weight-for-height\<-2 z-scores (WHZ) for wasting.

For women, Body Mass Index (BMI) was calculated as the body weight (in kg) divided by the square of height (in meters). Women were classified using BMI cut-off points endorsed by WHO as underweight (BMI\<18.5 kg/m^2^), normal (BMI of 18.5--24.9 kg/m^2^), overweight (BMI≥25 kg/m^2^) and obese (BMI ≥30 kg/m^2^) [@pone.0034906-WHO1]. As other specific cut-offs have been suggested for Asian populations a BMI of 23--27.49 kg/m^2^ was also used for overweight and a BMI ≥27.5 kg/m^2^ for obesity [@pone.0034906-WHO2].

Blood sampling and analysis {#s2d}
---------------------------

Just after anthropometry, a non-fasting blood sample was collected between 0700 and 0900 hours from women and children from the selected HH. Venous blood, 6 ml for women and 4 ml for children, was drawn by venipuncture in trace-element free heparinized sampling tubes (Vacuette, Greiner Bio One, Austria) by licensed medical technicians at the health center of the commune. Blood samples were stored in the dark in a cool box and transported within 4 hours of collection to the laboratory of Provincial Medical Center (PMC) for hemoglobin determination. Hemoglobin concentration (Hb) was then measured immediately using the HemoCue device (Hemocue 301, Ängelholm, Sweden) and control material provided by Hemocue and according to the manufacturer\'s instructions. Thereafter, plasma was obtained by centrifugation at 3000 g for 10 min at 4°C. Plasma was aliquoted into 200 µL pre-labeled Eppendorf tubes and kept frozen at −20°C at the PMC before being sent (within two weeks) on dry ice to the National Institute of Nutrition (NIN) where samples were stored at −70°C until analysis.

Plasma concentrations of ferritin (PF), retinol (PR), zinc (ZN), and C-reactive protein (CRP) were determined at the Micronutrient Laboratory of NIN. PF was measured by ELISA using commercial kits that included reference samples (Ramco Laboratories Inc, Houston, Texas). The accuracy was tested with Bio-Rad liquicheck control (Bio-Rad Laboratories, USA). PR concentration was determined by reverse-phase HPLC (LC-10 ADVP, Shimadzu, Japan) according to the method of the International Vitamin A Consultative Group in a dimly lighted room [@pone.0034906-IVACG1]. ZN was analyzed using a flame atomic absorption spectrophotometer (GBC, Avanta+) using trace element-free procedures, and powder free gloves (Latex Surgical Glove), and results were verified using reference materials (Liquicheck, Bio-Rad Laboratories, USA). A control for potential contamination of material used for blood sampling and blood treatment by external zinc was carried out by analyzing zinc content of at least 20 sets of material (needle, syringe, vacutainers and eppendorf tubes) where blood was replaced by bi-distilled water. CRP, an acute phase protein was used to quantify the acute phase response as a marker of inflammation and infection. Plasma CRP was measured by ELISA using a commercial kit from GenWay (Biotech, Inc., San Diego, California), with reference materials included in each assay (Liquicheck, Bio-Rad Laboratories, USA).

Aliquots of plasma were sent to the Swiss Vitamin Institute (Epalinges, Switzerland) for analysis of folate and vitamin B~12~ using a microbiological assay. For vitamin B~12~, a random plasma sample of 505 women of reproductive age was selected. For pre-school children, a random plasma sub-sample of 268 for folate analysis was selected but vitamin B~12~ was not analyzed. Extracted folates were diluted with basal medium containing all required growth nutrients except folate [@pone.0034906-European1]. The growth response of *Lactobacillus casei*, subspecies rhamnosus (ATCC 7469) to extracted folates was compared to the growth response to calibration solutions with known concentrations. Vitamin B~12~ was analyzed turbidimetrically using the growth of *Lactobacillus plantarum* (ATCC 8014) as test organism [@pone.0034906-BartonWright1], [@pone.0034906-Wiss1], [@pone.0034906-AOAC1]. The growth response of the organism is proportional to the quantity of vitamin B~12~ [@pone.0034906-Bui1]. The within-assay variability for plasma ferritin, retinol, folate, zinc, vitamin B~12~, and CRP was \<6%.

Anemia was defined according to WHO standards as Hb below 110 g/l for children aged from 6 months to 5 years, below 115 g/l for children from 5 to 11 years and 120 g/l for women of reproductive age [@pone.0034906-Allen1]. Iron deficiency (ID) was defined as PF \<12 µg/l for children 6--59 months and PF \<15 µg/L for children above 5 years of age and women [@pone.0034906-Allen1] and using a correction factor of 0.65 for ferritin concentration from subjects with sub-clinical inflammation as indicated by increased concentrations of CRP (\>5 mg/l) [@pone.0034906-Thurnham1]. Iron deficiency anemia (IDA) was defined as the combination of anemia and ID [@pone.0034906-Allen1]. Sub-clinical vitamin A deficiency was defined using WHO cut-offs as PR \<0.7 µmol/l [@pone.0034906-Allen1] while marginal status was defined as population with a PR between 0.7 and 1.05 µmol/l [@pone.0034906-dePee1] and plasma retinol concentrations were corrected where sub-clinical infection existed [@pone.0034906-Thurnham2]. Zinc deficiency was defined using the International Zinc Nutrition Consultative Group (IZiNCG) cutoffs by ZN \<9.9 µmol/l for children and ZN\<10.1 µmol/l for women [@pone.0034906-Gibson1]. Vitamin B~12~ deficiency was defined as plasma vitamin B~12~ values below 148 pmol/l, and marginal status when the concentration was between 148--220 pmol/l [@pone.0034906-Jones1]. Folate deficiency and marginal status were considered when plasma folate was respectively below 6.8 nmol/l and between 6.8--13.4 nmol/l [@pone.0034906-Jones1].

Socioeconomic status {#s2e}
--------------------

Socio-economic status was calculated from data obtained during the 2009 FCS [@pone.0034906-Rustein1], using the Demographic Health Statistic (DHS) Wealth Index to divide households surveyed into five socio-economic quintiles: the "extreme poor" (category 1), the" poor" (category 2), the "intermediate" categories 3 and 4 and the "wealthiest" (category 5). The Wealth Index was constructed from recorded data on household assets such as tables, chairs, refrigerator, air conditioners and beds and also from housing conditions (materials of house floor, house roof, main wall) and facilities (energy for cooking, electricity and latrines), income and expenditure were not used [@pone.0034906-Rutstein1].

Ethical issues {#s2f}
--------------

The Scientific Committees of the National Institute of Nutrition (NIN) (Hanoi, Vietnam) and of the Ministry of Health (Hanoi, Vietnam) reviewed and approved the study protocol. All women were informed verbally and in writing about the aims and procedures of the study, and written informed consent was obtained from all women and children, via their mother or guardian approval for these later, before enrollment.

Statistical analysis {#s2g}
--------------------

Data entry, including quality checks was performed with Excel 2007™. Data management and analysis were performed with SAS software version 9.2™ (SAS, V9.2; SAS institute, Cary, NC). All analysis took into account characteristics of the cluster sampling design using the appropriate survey procedures of SAS (surveyfreq and surveymeans procedures as introduced in SAS Institute Inc. 2008) [@pone.0034906-SASSTAT1]. Qualitative variables were expressed as percentages and standard error percentage. Continuous variables were expressed as arithmetic means and standard error of the mean except ferritin whose data were not normally distributed. For, ferritin, concentrations were log-transformed before statistical analysis, and are expressed as geometric means.

Associations between prevalence and region or area (urban/rural) were assessed using univariate logistic regression models (surveylogistic procedure). Associations between continuous variables and region or area were assessed using univariate linear regression models (surveyreg procedure). The first type error rate was set at 0.05.

Logistic regression models with micronutrient prevalence as the response variable were used to assess the effect of the different factors (urban or rural area, socioeconomic class and age class for children) and to estimate Odd Ratios (OR).

Results {#s3}
=======

In total, 1526 women and 586 children from 1526 households, 51.6% urban, and 48.4% rural, were surveyed. Among the children, 53.7% were male and 46.3% female. The majority of the surveyed women were from the Kinh ethnic group (86.2%). 15.4% had no education degree, 22.6% had completed primary schooling, 30.7% were secondary school graduates, and 31.3% high school graduates or more. Among households, 16.5% were classified in the "extreme poor" category (category 1), 15.0% in the poor category (category 2), 18.5% in intermediate category 3 and 21.0% in category 4, and 29.1% in the "wealthiest" (category 5).

Anthropometric characteristics of the surveyed women are shown in [table 1](#pone-0034906-t001){ref-type="table"}, respectively, disaggregated by rural and urban strata. The age range of women was 15 to 50 years ([Table 1](#pone-0034906-t001){ref-type="table"}). Among them, 20.5% were classified as underweight, significantly more in rural than in urban area. Less than 10% of the women were classified as overweight or obese, according to the international reference. Using Asian reference, more than 20.0% of the women were classified as overweight or obese. Prevalence of overweight (including obesity) was not significantly different between urban and rural populations with the international reference but significantly higher in the urban population when the Asian reference was applied 22.3% (±1.5%) in urban and 17.9% (±1.4%) in rural area (p\<0.05). This double burden is represented in all socioeconomic groups of women with significantly higher overweight and obesity and lower underweight in the two wealthiest groups (p\<0.001).

10.1371/journal.pone.0034906.t001

###### Nutritional characteristics of women and young children.

![](pone.0034906.t001){#pone-0034906-t001-1}

                                                    National   Urban   Rural    p                                                                  
  ------------------------------------------------ ---------- ------- ------- ----- ------- ----- ----- ----------- ----- ------- ----- ----- ---- --------
  **Women of reproductive age**                                                                                                                    
  Age (in years)                                      1502     32.3     0.3    730   32.7    0.4   0.9   −0.1--1.9   772   31.9    0.3   0.0   \-    0.09
  Weight (kg)                                         1502     48.6     0.2    730   49.2    0.3   1.2   0.2--2.1    772   48.0    0.4   0.0   \-    0.02
  Height (cm)                                         1501     152.7    0.2    729   152.9   0.3   0.3   −0,5--1.1   772   152.5   0.3   0.0   \-    0.42
  BMI (kg/m^2^)[\*](#nt101){ref-type="table-fn"}      1501     20.8     0.1    729   21.1    0.1   0.4   0.1--0.8    772   20.6    0.1   0.0   \-    0.01
  \] -inf −18.5 \[(%)                                 1501     20.5     1.3    729   17.6    1.5   0.7   0.5--0.9    772   23.3    2.0   1.0   \-    0.02
  \[18.5--25 \[(%)                                    1501     71.5     1.4    729   74.1    1.8   1.3   1.0--1.7    772   69.0    2.1   1.0   \-    0.07
  \[25--30 \[(%)                                      1501      7.4     0.7    729    7.4    1.0   1.0   0.7--1.5    772    7.4    1.1   1.0   \-    0.98
  \[30 - +inf \[(%)                                   1501      0.6     0.2    729    1.0    0.3   3.7   0.8--17.4   772    0.3    0.2   1.0   \-    0.09
  **young children**                                                                                                                               
  Age (in months)                                     565      44.8     0.9    256   45.1    1.0   0.4   −3.0--3.8   309   44.7    1.4   0.0   \-    0.81
  Weight (kg)                                         561      13.9     0.2    247   14.4    0.3   1.1   0.3--1.9    307   13.5    0.2   0.0   \-    0.02
  Height (cm)                                         563      95.3     0.6    245   96.2    0.8   2.1   −0.3--4.4   303   94.5    0.9   0.0   \-    0.14
  WHZ[\*](#nt101){ref-type="table-fn"}                557      −0.4     0.1    250   −0.2    0.1   0.4   0.1--0.6    307   −0.6    0.1   0.0   \-    0.01
  wasting (%)                                         557       6.3     1.2    250    5.2    1.8   0.7   0.3--1.7    307    7.2    1.7   1.0   \-    0.44
  WAZ[\*](#nt101){ref-type="table-fn"}                558      −1.0     0.1    250   −0.7    0.1   0.5   0.1--0.8    308   −1.2    0.1   0.0   \-   \<0.01
  underweight (%)                                     558      18.1     2.0    250   14.8    2.2   0.7   0.4--1.1    308   20.8    3.2   1.0   \-    0.11
  HAZ[\*](#nt101){ref-type="table-fn"}                552      −1.1     0.1    249   −0.9    0.1   0.4   0.1--0.7    303   −1.3    0.1   0.0   \-    0.02
  stunting (%)                                        552      23.2     2.6    249   18.9    3.5   0.6   0.4--1.1    303   26.7    3.6   1.0   \-    0.13

:Body Mass Index (BMI), weight-for-age\<-2z-scores (WAZ) for underweight, height-for-age\<-2 z-scores (HAZ) for stunting and weight-for-height\<-2 z-scores (WHZ) for wasting.

SEP: standard of error of the prevalence; SEM: standard error of the mean.

: IC: interval of confidence; OR: Odd Ratio.

few children (21 over 586) and women (24 over 1526) did not have any anthropometric measurements.

Micronutrient status of women is also presented in [table 2](#pone-0034906-t002){ref-type="table"}. Anemia prevalence was affecting approximately 12% of women; Prevalence of ID was present in approximately 14% of women, with 5.4% of the women classified as IDA. The prevalence of zinc deficiency was much higher, affecting two-third of the women. The prevalence of vitamin A deficiency was \<2% in women whereas approximately 14% had a marginal vitamin A status. Prevalence of folate deficiency was \<3% whereas marginal folate status affected one fourth of women. Prevalence of vitamin B~12~ deficiency was 12%, with an additional 4% of the women having a marginal status.

10.1371/journal.pone.0034906.t002

###### Vitamins and mineral status indicators and prevalence of deficiencies among women of reproductive age.

![](pone.0034906.t002){#pone-0034906-t002-2}

                                                               Global   Urban   Rural    p                                                                          
  ----------------------------------------------------------- -------- ------- ------- ----- ------- ------ ------- -------------- ----- ------- ------ ------ ---- ------
  Hb (g/l)                                                      1526    131.4    0.4    740   131.7   0.5     0.1     −0.1--0.2     786   131.1   0.5    0.0    \-   0.39
  Iron status                                                                                                                                                       
  Anemia (%)                                                    1526    11.6     1.0    740   11.0    1.4     0.9      0.6--1.3     786   12.2    1.6    1.0    \-   0.54
  Ferrintin (µg/l)[\*](#nt105){ref-type="table-fn"}             1523    48.5     1.0    739   60.0    1.1                           784   45.5    1.1                0.06
  Iron deficiency (%)                                           1523    13.7     1.1    739   11.8    1.3     0.7      0.5--1.0     784   15.6    1.8    1.0    \-   0.09
  Iron deficiency anemia (%)                                    1522     5.4     0.7    738    4.6    0.8     0.7      0.5--1.2     784    6.1    1.0    1.0    \-   0.24
  Vitamin A status                                                                                                                                                  
  Plasma retinol (µmol/l)                                       1475    1.49    0.02    706   1.48    0.03   −0.02   −0.11--0.06    769   1.50    0.03   0.00   \-   0.58
  Vitamin A deficiency (%)                                      1475     1.6     0.3    706    1.6    0.5     1.0      0.4--2.3     769    1.6    0.4    1.0    \-   0.99
  Marginal status (%)                                           1475    13.6     1.0    706   14.2    1.5     1.1      0.8--1.5     769   13.1    1.4    1.0    \-   0.62
  Zinc status                                                                                                                                                       
  Plasma zinc (µmol/l)                                          1522     9.5     0.1    739    9.7    0.2     0.4     −0.1--0.9     783    9.3    0.2    0.0    \-   0.13
  Zinc deficiency (%)                                           1522    67.2     2.6    739   62.9    3.8     0.7      0.4--1.1     783   71.1    3.6    1.0    \-   0.12
  Folate status                                                                                                                                                     
  Plasma folate (nmol/l)[\*\*](#nt106){ref-type="table-fn"}     1472    17.6     0.6    705   16.5    0.8    −1.8     −5.7--2.1     767   18.7    0.7    0.0    \-  
  Folate deficiency (%)                                         1472     2.7     0.6    705    2.8    0.6     1.1      0.5--2.7     767    2.5    0.9    1.0    \-   0.75
  Marginal status (%)                                           1472    25.1     1.6    705   27.7    2.5     1.3      0.9--1.8     767   22.8    2.2    1.0    \-   0.14
  Vitamin B12 status                                                                                                                                                
  Plasma B12 (pmol/l)                                           505     630.3   23.1    230   668.9   33.4   70.9    −20.1--164.8   275   598.0   31.4   0.0    \-   0.13
  B12 deficiency (%)                                            505     11.7     1.7    230   11.7    2.5     1.0      0.5--1.9     275   11.6    2.2    1.0    \-   0.97
  Marginal status (%)                                           505      3.8     1.1    230    2.2    1.0     0.4      0.1--1.3     275    5.1    1.8    1.0    \-   0.13
  Inflammation                                                                                                                                                      
  CRP (mg/l)                                                    1518     1.8     0.1    736    2.1    0.2     0.5      0.0--1.0     782    1.6    0.1    0.0    \-   0.03
  High CRP (%)                                                  1518     6.8     0.6    736    8.0    0.9     1.5      1.0--2.2     782    5.6    0.9    1.0    \-   0.07

geometric mean.

median values.

The sample size varied slightly for each micronutrient analysis because of insufficient blood quantity among some participants.

The age range of children was 10 to 75 months: 23% was stunted and 6% wasted. In contrast, 7% of the children were overweight or obese. Anemia prevalence was close to 10%, ID was 13% with 3% of the children having IDA ([Table 3](#pone-0034906-t003){ref-type="table"}). The prevalence of zinc deficiency was high, affecting more than half of the children, and significantly more prevalent in rural than in urban areas. The prevalence of Vitamin A deficiency was 10% whereas almost half of children had a marginal vitamin A status. Folate deficiency was less than 1% in children and marginal folate approximately 6%, with urban children being more affected by marginal-deficient status than rural children (p\<0.05). [Figure 1](#pone-0034906-g001){ref-type="fig"} shows the prevalence of the micronutrient deficiencies according to the age. There was a clear effect of age on anemia prevalence and iron status, with the youngest age group (6--17 mo) having the highest risk for anemia and IDA as compared to the other groups (table S1). For zinc and vitamin A deficiency, age was a less strong factor, although the risk for deficiency or marginal status was highest in the youngest age group.

![Prevalence of micronutrient deficiencies among young children by age groups (in %).\
ID: iron deficiency; IDA: iron deficiency anemia, ZnD: zinc deficiency, VAD: vitamin A deficiency; mo: months.](pone.0034906.g001){#pone-0034906-g001}

10.1371/journal.pone.0034906.t003

###### Vitamins and mineral status indicators and prevalence of deficiencies among young children.

![](pone.0034906.t003){#pone-0034906-t003-3}

                                                               Global   Urban   Rural    p                                                                        
  ----------------------------------------------------------- -------- ------- ------- ----- ------- ------ ------ ------------- ----- ------- ------ ------ ---- --------
  Hb (g/l)                                                      583     125.3    0.1    262   125.8   0.1    0.1     −0.2--0.3    321   125.0   0.1    0.0    \-    0.51
  Iron status                                                                                                                                                     
  Anemia (%)                                                    583      9.1     1.4    262    8.0    2.1    0.8     0.4--1.6     321   10.0    1.9    1.0    \-    0.50
  Ferrintin (µg/l)[\*](#nt108){ref-type="table-fn"}             568     33.8     1.0    259   32.1    1.1                         309   35.3    1.1                 0.21
  Iron deficiency (%)                                           568     12.9     1.5          14.7    2.4    1.3     0.8--2.3           11.3    2.0    1.0    \-    0.27
  Iron deficiency anemia (%)                                    564      3.2     0.8    258    1.9    1.2    0.4     0.1--1.8     306    4.3    1.1    1.0    \-    0.25
  Vitamin A status                                                                                                                                                
  Plasma retinol (µmol/l)                                       546     1.04    0.02    242   1.06    0.04   0.05   −0.05--0.15   304   1.02    0.03   0.00   \-    0.35
  Vitamin A deficiency (%)                                      546     10.1     1.6    242    8.7    2.3    0.8     0.4--1.5     304   11.2    2.2    1.0    \-    0.43
  Marginal status (%)                                           546     47.3     2.2    242   42.6    3.2    0.7     0.5--1.0     304   51.0    3.1    1.0    \-    0.06
  Vitamin A deficiency and Marginal(%)                          546     57.3     2.7    242   51.2    3.4    0.6     0.4--1.0     304   62.2    3.9    1.0    \-    0.04
  Zinc status                                                                                                                                                     
  Plasma zinc (µmol/l)                                          563     10.2     0.2    257   10.8    0.3    1.1     0.3--1.8     306    9.7    0.2    0.0    \-   \<0.01
  Zinc deficiency (%)                                           563     51.9     3.5    257   42.0    5.0    0.5     0.3--0.8     306   60.1    4.7    1.0    \-   \<0.01
  Folate status                                                                                                                                                   
  Plasma folate (nmol/l)[\*\*](#nt109){ref-type="table-fn"}     327     25.4     1.1    147   22.3    1.7    −4.5   −17.0--8.0    180   26.7    1.3    0.0    \-    0.48
  Folate deficiency (%)                                         327      0.6     0.4    147    1.4    0.9     \-        \-        180     0      \-    1.0    \-   \<0.01
  Marginal status (%)                                           327      6.4     1.5    147    9.5    2.7    2.6     0.9--7.1     180    3.9    1.5    1.0    \-    0.06
  Folate deficiency and Marginal(%)                             327      7.0     1.6    147   10.9    3.1    3.0     1.1--8.3     180    3.9    1.5    1.0    \-    0.03
  Inflammation                                                                                                                                                    
  CRP (mg/l)                                                    566      2.7     0.5    258    2.0    0.3    −1.3    −3.0--0.5    308    3.3    0.8    0.0    \-    0.16
  High CRP (%)                                                  566     10.8     1.4    258   11.2    2.0    1.1     0.6--1.9     308   10.4    2.0    1.0    \-    0.76

geometric mean.

median values.

The sample size varied slightly for each micronutrient analysis because of insufficient blood quantity among some participants.

Data were also analyzed by socio-economic (SE) categories. Women in the poorest category had approximately 2 times higher risk for anemia and ID than women in the other categories ([table 4](#pone-0034906-t004){ref-type="table"} and [figure 2](#pone-0034906-g002){ref-type="fig"}). Zinc deficiency showed a trend going in the same direction with prevalence decreasing from 77% to 60% from the poorest to the wealthiest category whereas the risk for vitamin A marginal status was in contrast significantly lower in the poorest category 1. The risks for folate or vitamin B12 deficiencies were not significantly different among SE categories. In children ([table 5](#pone-0034906-t005){ref-type="table"} and [figure 3](#pone-0034906-g003){ref-type="fig"}), the risk for zinc deficiency and vitamin A deficiency and marginal status was significantly higher in the poorest category.

![Prevalence of micronutrient deficiencies among women of reproductive age by socioeconomic groups\* (in %).\
\*note: Socio-economic categories: 1: the "extreme poor"; 2: the "poor", 3 and 4: the "intermediate" and 5: the "wealthiest". Sample size respectively for category 1,2,3,4 and 5: Anemia (n = 248, 226, 279, 319 and 440); ID (n = 246, 227, 278, 319, 439); Vitamin A deficiency and marginal status (n = 240, 219, 260, 313, 429); ZD (n = 247, 227, 277, 319, 438); folate deficiency and marginal status (n = 245, 221, 261, 304, 428); vitamin B12 deficiency and marginal status (n = 67, 80, 106, 98, 150).](pone.0034906.g002){#pone-0034906-g002}

![Prevalence of micronutrient deficiencies among young children by socioeconomic groups\* (in %).\
\*note: Socio-economic categories: 1: the "extreme poor"; 2: the "poor", 3 and 4: the "intermediate" and 5: the "wealthiest". Sample size respectively for category 1,2,3,4 and 5: Anemia (n = 131, 91, 92, 110, 154); ID (n = 132, 89, 88, 105, 150); Vitamin A deficiency and marginal status (n = 129, 88, 84, 97, 144); ZD (n = 130, 89, 88, 103, 150); folate deficiency and marginal status (n = 63,48, 59, 64, 93).](pone.0034906.g003){#pone-0034906-g003}

10.1371/journal.pone.0034906.t004

###### Prevalence of vitamins and mineral deficiencies among women by socioeconomic categories.

![](pone.0034906.t004){#pone-0034906-t004-4}

                               1     2      3     4     5      p                                                                                                                                
  -------------------------- ----- ------ ----- ----- ------ ----- ----- ---------- ----- ------ ----- ----- ---------- ----- ------ ----- ----- ---------- ----- ------ ----- ----- ---------- --------
  Iron status                                                                                                                                                                                   
  Anemia (%)                  248   20.6   3.0   226   11.5   2.3   0.5   0.3--0.9   279   7.5    1.7   0.3   0.2--0.6   319   9.4    1.7   0.4   0.2--0.7   440   10.7   1.7   0.5   0.3--0.8   \<0.01
  Iron deficiency (%)         246   20.7   3.4   227   11.9   2.7   0.5   0.3--0.9   278   15.1   2.1   0.7   0.4--1.1   319   11.9   2.0   0.5   0.3--0.9   439   11.2   1.6   0.5   0.3--0.8    0.04
  Vitamin A status                                                                                                                                                                              
  Vitamin A deficiency (%)    240   2.1    0.9   219    0     \-    \-       \-      260   1.5    0.7   0.7   0.2--2.2   313   1.6    0.7   0.8   0.2--2.6   429   2.1    0.7   1.0   0.3--3.1   \<0.01
  Marginal status (%)         240   7.5    1.6   219   15.1   2.7   2.2   1.2--4.0   260   14.6   2.3   2.1   1.2--3.6   313   15.0   2.0   2.2   1.3--3.8   429   15.2   2.0   2.2   1.3--3.7    0.03
  Zinc status                                                                                                                                                                                   
  Zinc deficiency (%)         247   77.7   3.8   227   71.8   4.1   0.7   0.4--1.2   277   63.9   4.5   0.5   0.3--0.8   319   69.3   3.5   0.6   0.4--1.1   438   59.6   4.0   0.4   0.2--0.7   \<0.01
  Folate status                                                                                                                                                                                 
  Folate deficiency (%)       245   3.7    1.3   221   2.7    1.2   0.7   0.2--2.2   261   3.8    1.5   1.0   0.4--2.9   304   1.6    0.7   0.4   0.1--1.4   428   1.9    0.7   0.5   0.2--1.4    0.37
  Marginal status (%)         245   26.9   2.8   221   24.9   3.2   0.9   0.6--1.3   261   27.6   3.1   1.0   0.7--1.5   304   27.6   3.5   1.0   0.7--1.6   428   21.5   2.4   0.7   0.5--1.1    0.27
  Vitamin B12 status                                                                                                                                                                            
  B12 deficiency (%)          67    10.4   3.9   80    10.0   3.5   1.0   0.3--3.1   106   10.4   3.6   1.0   0.3--3.0   98    14.3   3.4   1.4   0.5--3.9   150   12.7   2.7   1.2   0.5--3.2    0.79
  Marginal status (%)         67    6.0    2.5   80    2.5    2.4   0.4   0.1--2.2   106   3.8    2.3   0.6   0.1--2.9   98    2.0    1.4   0.3   0.1--1.7   150   4.7    1.7   0.3   0.1--1.7    0.55

SEP: standard of error of the prevalence; SEM: standard error of the mean; IC: interval of confidence; OR: Odd Ratio.

10.1371/journal.pone.0034906.t005

###### Prevalence of vitamins and mineral deficiencies among children by socioeconomic categories.

![](pone.0034906.t005){#pone-0034906-t005-5}

                               1     2      3    4     5      p                                                                                                                               
  -------------------------- ----- ------ ----- ---- ------ ----- ----- ---------- ---- ------ ----- ----- ---------- ----- ------ ----- ----- ---------- ----- ------ ----- ----- ---------- --------
  Iron status                                                                                                                                                                                 
  Anemia (%)                  131   13.7   3.2   91   8.8    3.2   0.6   0.2--1.5   92   7.6    2.7   0.5   0.2--1.2   110   10.9   3.4   0.8   0.3--1.8   154   5.2    2.3   0.3   0.1--1.0    0.21
  Iron deficiency (%)         132   12.1   3.4   89   9.0    3.4   0.7   0.2--2.1   88   13.6   3.5   1.1   0.5--2.6   105   12.4   3.3   1.0   0.4--2.5   150   16.0   3.4   1.4   0.6--3.0    0.68
  Vitamin A status                                                                                                                                                                            
  Vitamin A deficiency (%)    129   14.0   3.6   88   6.8    3.1   0.5   0.2--1.4   84   6.0    2.6   0.4   0.1--1.1   97    13.4   3.9   1.0   0.4--2.2   144   9.0    2.5   0.6   0.3--1.4    0.29
  Marginal status (%)         129   55.0   4.7   88   61.4   7.0   1.3   0.6--2.7   84   48.8   5.6   0.8   0.5--1.3   97    38.1   5.4   0.5   0.3--0.9   144   36.8   3.7   0.5   0.3--0.8   \<0.01
  Zinc status                                                                                                                                                                                 
  Zinc deficiency (%)         130   66.9   5.1   89   60.0   6.9   0.7   0.4--1.4   88   53.4   6.6   0.6   0.3--1.1   103   49.5   6.1   0.5   0.3--0.9   150   34.0   5.3   0.3   0.1--0.5   \<0.01
  Folate status                                                                                                                                                                               
  Folate deficiency (%)       63     0     \-    48    0     \-     1    0.6--1.7   59   1.7    1.7   \-       \-      64     0            1    0.6--1.7   93    1.1    1.1   \-       \-      \<0.01
  Marginal status (%)         63    6.3    3.5   48   8.3    3.6   1.3   0.3--6.7   59   6.8    4.0   1.1   0.2--6.0   64    9.4    4.3   1.5   0.3--6.9   93    3.2    1.8   0.5   0.1--2.5    0.67

SEP: standard of error of the prevalence; SEM: standard error of the mean; IC: interval of confidence; OR: Odd Ratio.

Discussion {#s4}
==========

This study showed that according to the WHO classification [@pone.0034906-Allen1] the prevalence of anemia was a mild public health problem (\[5.0--20\[% [@pone.0034906-World1]) in both the women of reproductive age and children aged from 0.5 to 7 years. Vitamin A deficiency was also recognized as a mild public health problem (≥10% of the population) among young children as more than 10% were deficient [@pone.0034906-Allen1], [@pone.0034906-World2] but not in women. Zinc deficiency was notably high in both women and children representing a severe public health concern (≥25% among children under 5 years of age) [@pone.0034906-Gibson2]. Folate deficiency was not of concern in both population groups whereas the prevalence of low serum vitamin B12 among women, two times higher than the cut-off of 5%, pointed out a country-wide public health problem [@pone.0034906-McLean1].

In the 2000 "National Anemia, Nutrition and Risk Factor Survey", anemia prevalence in Vietnam was 34% in children under five years of age and 25% in women of reproductive age [@pone.0034906-Ninh1]. In the present study, the prevalence of anemia in women and children is much less, suggesting a substantial improvement in the prevalence of anemia over the last decade. Several factors might have contributed to these findings. Firstly, the health authorities in Vietnam have included the prevention of iron deficiency in their 2001--2010 National Plan of Action for Nutrition [@pone.0034906-MOHNIN1]. The strategy focused on reducing child malnutrition and low birth weights, and also vitamin A, iron and iodine deficiencies through supplementation, and food diversification and fortification. Secondly, from the late 1990\'s to 2005, the *per capita* income in Vietnam increased from US\$300 to more than US\$400 [@pone.0034906-Ecker1], [@pone.0034906-WDI1], [@pone.0034906-FSS1], and child malnutrition was improved with a decline from 1990 to 2010 of stunting from 56.5% to 29.3% and underweight from 51.5% to 17.5% [@pone.0034906-Khan1], [@pone.0034906-NIN1]. Evidence from South East Asia shows that economic growth generally leads to improvement in human nutrition [@pone.0034906-Ecker1]. In Vietnam, the increase of income since the 1990\'s is associated with an increased consumption of meats, fish and fruits [@pone.0034906-Hople1] which are mainly rich source of heme iron and/or enhancing factors for non-heme iron absorption [@pone.0034906-Ta1].

We cannot discard the possibility that the method used in this study to measure hemoglobin concentrations has impacted the results. Indeed, in the present study, the hemoglobin concentration was measured with the new HemoCue Hb301® device and a recent study showed that this device yields slightly higher values (+0.5 g/dL) than the Hemocue Hb201® device used in most of the previous studies in Vietnam [@pone.0034906-TayouTagny1]. However, using cut-offs for anemia increased by 5 g/L to correct for this, anemia would be present in 16.0% (CI: 12.3--19.8 g/L%) of the children and 21.4% (CI: 19.0--23.8%) of the women without significant difference between urban and rural populations. Hence, still lower than the anemia prevalence data from 2000.

The measure of iron stores, that is not often included in national surveys, indicated that the prevalence of iron deficiency was also low and associated to approximately half or less of the anemia cases, suggesting others causes than iron for anemia, such as other micronutrients deficiencies (vitamin A, folate or VitB~12~) or hemoglobinopathies as malaria was not an important issue in the present study. Hemoglobinopathies can cause a shift to the left in the Hb distribution, leading to more people having hemoglobin concentrations below the relevant cut-offs, without having clear physiological consequences. In addition, chronic inflammation (e.g. intestinal parasites) can lead to anemia through reduced erythropoiesis (a reduction in red blood cell production by the bone marrow). Unfortunately, we do not have data to identify which of these factors underlies the anemia in our cohort. Moreover, half of the ID was not associated with anemia suggesting that daily iron intake in these subjects was sufficient to allow normal physiological functions but not adequate to build iron stores. Over 25% of children and women had a ferritin concentration \<30 µg/l that indicates low iron stores (less than 180--200 mg of iron). This is especially important for women of reproductive age as iron stores of 300--500 mg before pregnancy are recommended [@pone.0034906-Viteri1]. Anemia has many etiologies, iron deficiency being only one of them.

In children, the stratification of anemia, ID and IDA by age group showed that the prevalence and risk of anemia, iron deficiency and iron deficiency anemia was significantly higher in the 6--17 mo. age group. In this age group, the prevalence of anemia was considered as a moderate public health problem and most of anemia was associated with iron deficiency. More than half of children had ID, a finding consistent with intervention trials carried out in previous years in Vietnamese infants and young children [@pone.0034906-Phu1], [@pone.0034906-Berger2], [@pone.0034906-Hople2]. In older children risk for anemia and ID was much lower, although still high for the 18--23 mo group (∼30%). A recent situational review of infant and young child feeding practices in Viet Nam showed that exclusive breastfeeding until 6 months is rare in Vietnam [@pone.0034906-Nguyen1]. The article also suggested that complementary foods for young children have low energy density, low protein and micronutrient content as rice flour and rice porridge are the most common used food, which might increase the risk of iron deficiency anemia. The strong effect of age on anemia and iron status is probably due to access of the children to a more diversified diet, perhaps with fortified products such as fish sauce, and to lower iron needs [@pone.0034906-WHO3].

Very few countries have national data on zinc deficiency measured through plasma zinc. Indeed, most of data on zinc deficiency are obtained from prevalence of zinc intakes below the EAR, and of stunted children less than 5 years of age [@pone.0034906-Gibson2], [@pone.0034906-Black1], [@pone.0034906-deBenoist1]. Although plasma zinc is often questioned as a marker for individual zinc status, it is still a reliable marker on population level [@pone.0034906-Brown1], [@pone.0034906-Hess1]. One of the main concerns with plasma zinc is the potential contamination of blood samples that may lead to underestimate the prevalence of zinc deficiency. In this survey material and procedure were controlled for contamination. The high prevalence of zinc deficiency in both women and children in this survey is intriguing, although consistent with several intervention trials carried-out in Vietnam in the recent years which indicated zinc deficiency prevalence ranging from 32% to 67% in young children under 2 years of age [@pone.0034906-Phu1], [@pone.0034906-Hople2] and of 52.1% among rural primary schoolchildren aged 6 to 8 years of age [@pone.0034906-Nga1]. Moreover, according to a recent review assessing the risk of zinc deficiency, South and Southeast Asia, appear to be at the highest risk of zinc deficiency [@pone.0034906-Brown1]. In Southeast Asia, 6 over 10 evaluated countries were categorized as high risk countries for zinc deficiency, including Vietnam [@pone.0034906-Hotz1]. Considering children under 2 years of age, 30.1% were stunted and 56.2% had zinc deficiency. This would suggest that data on stunting, without zinc dietary assessment, as a proxy for zinc deficiency is not relevant. In addition, stunting is a cumulative phenomenon due to many causes and it is difficult to link stunting to a single measure of plasma zinc.

Vitamin A deficiency as well as marginal vitamin A status was low in women and much higher in children. The most recent survey conducted in 2000 in 4 ecological regions of Vietnam showed a prevalence of VAD in children under 2 years of age of 15% [@pone.0034906-National1]. Now, a decade later, VAD prevalence was not notably lower as 11.8% in the children under two years of age, and 11.9% of the children between 2 to 5 years of age were VAD deficient. More than half of children had a marginal or deficient vitamin A status with a significant higher risk for the youngest. This high prevalence of marginal vitamin A status would suggest that efforts to prevent vitamin A deficiency have to be maintained and even strengthened especially for the under 2 year old children. Eliminating vitamin A deficiency through vitamin A supplementation has been the focus of universal efforts. However, two studies in the Philippines and India show that the effect of high dose vitamin A capsules last between 2--3 mo with no more effect after 6 mo. [@pone.0034906-Pereira1], [@pone.0034906-Perlas1]. This would suggest that other complementary types of intervention, such as food fortification or food diversification should be planed and evaluated.

Very few countries, especially from Asia have national data on folate or vitamin B~12~ status [@pone.0034906-McLean1]. The low prevalence of folate deficiency in women in this survey is in agreement with a recent study conducted in 2006 among women living in Hanoi and Hai Phuong provinces that did not show evidence of folate and vitamin B~12~ deficiencies [@pone.0034906-Vu1]. However, approximately one third of women in our survey had a marginal folate status. In the 2006 study, suboptimal folate status, measured on red blood cell folate concentration, was also much higher (60%) than folate deficiency, warranting special attention to ways to improve folate status also. Our study may also suggest that marginal folate status is affecting women more than young children, a finding not described before. In contrast with the 2006 study, vitamin B~12~ deficiency represented a public health problem in our survey. This situation could place the future babies at increased risk for neural tube defects as deficient or inadequate maternal vitamin B~12~ and folate are associated with a significantly increased risk for neural tube defects [@pone.0034906-Molloy1], [@pone.0034906-KIRKE1]. The marginal folate and vitamin B~12~ status found here and the fact that adequate folate and vitamin B~12~ status one month before pregnancy and during the first trimester of pregnancy are strongly recommended [@pone.0034906-Allen2] suggest that preventive measures to increase intakes of folate and B~12~ should be taken into consideration.

Prevalence of micronutrient deficiencies differed according to socio-economic levels. The highest risk for anemia, iron and zinc deficiency in the poorest category of women and children was probably due to the lowest consumption of food containing bio-available iron and zinc such as meat or fish as demonstrated in a recent study [@pone.0034906-Dienle1]. Risk of marginal vitamin A status was also significantly higher among the poorest children but surprisingly lower among women. At this stage, we cannot propose any explanation until the analysis of food consumption data has been completed.

This survey showed also that Vietnam is facing the so-called double burden of malnutrition, with on one side, women with overweight (20%) and on the other side women with underweight (20%) or/and micronutrient deficiencies. Those results confirms previous findings which emphasize the Vietnamese nutrition transition [@pone.0034906-Khan2]. This double burden is represented in all socioeconomic groups of women with significantly higher overweight and obesity and lower underweight in the two higher wealthiest groups. This survey shows that overweight and obesity, measured with international reference, increased over the last decade. The two last Vietnamese Living Standard Surveys *(VLSS)* show that the prevalence of overweight in Vietnamese adults doubled between 1992 and 2002, from 2% to 5.5%, respectively [@pone.0034906-Nguyen2], and to 8% in this survey. Moreover, the prevalence of overweight and obesity measured with the Asian BMI cut-off in our study was higher (22.4%) than in the 2005 National Adult Obesity survey that was 16.3% [@pone.0034906-Hado1]. In contrast, the prevalence of underweight did not change notably between 2005 and now. In this survey, the prevalence of overweight (including obesity) was significantly higher in the urban population. This is reinforced by the prevalence of 33.2% of overweight and obesity found in 2005 in a representative sample of 1,971 adults aged 25--64 years living in Ho Chi Minh City (HCMC) [@pone.0034906-Trinh1]. The magnitude of overweight (measured with international cut-offs) is still much less in Vietnam than in many of the neighboring countries. In Thailand, the National Health Examination Survey II showed a prevalence of overweight in adults aged 20--59 years of 28%, with highest values in women (33.9%) and in the urban population (34.8%) [@pone.0034906-Aekplakorn1]. The problem of overweight and obesity is also rapidly increasing in China in all gender and age groups and in geographical areas, particularly in the urban area, with overall reported prevalence rates of 15% in 1992 and 22% in 2002 [@pone.0034906-Wang1]. Other countries in the region are also hit by over-nutrition as 29% of the adults in Hong Kong [@pone.0034906-Ko1] and 26.7% in South-Korea [@pone.0034906-Kim1] are classified overweight or obese.

Conclusion {#s4a}
----------

One of the main new findings of this survey was that zinc deficiency is a severe public health problem among women in reproductive age and in children age 6--75 mo. In women, Vitamin B~12~ deficiency was also a concern. In contrast, in both population groups, the prevalence of anemia, iron and vitamin A deficiency have decreased compared to previous surveys. However, marginal anemia and marginal vitamin A status are still prevalent. The other main finding was that the group of children from 6 to 18 months of age was particularly at risk for micronutrient deficiencies. Consequently specific interventions for this age group to improve food diversity and quality should be implemented. Among them, the micronutrient fortification of staple foods and condiments as well as special attention to complementary feeding could contribute to prevent the Vietnamese population from becoming micronutrient deficient, and need to be explored.
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